Sandra Salter is a Lecturer and Research Fellow in the Pharmacy Division of the School of Allied Health at The University of Western Australia. Her research focuses on the management of anaphylaxis in the community setting. The incidence and prevalence of anaphylaxis has dramatically increased over the past two decades, and Australia now has the highest incidence of allergy in the world.
Sandra is the Chief Investigator in the Epidemiology of Anaphylaxis in Western Australia study, and also leads research into the use, storage and stability of EpiPens. In Australia, pharmacists are the key suppliers of EpiPens – devices intended for emergency treatment of anaphylaxis in the community.
Sandra’s prior research resulted in the development and release of the Australasian Society of Clinical Immunology and Allergy (ASCIA) Anaphylaxis Checklist for Pharmacists, a tool to optimise emergency and long-term management of patients with anaphylaxis.
Sandra has collaborated with ASCIA and with Allergy and Anaphylaxis Australia as part of the National Allergy Strategy. Her collaborative research currently focuses on the real-world impacts of EpiPen carriage and storage, and associated effects on stability of epinephrine, the medicine inside the EpiPen.
Sandra acknowledges the support of the WA Department of Health, the Australasian Society of Clinical Immunology and Allergy, Allergy and Anaphylaxis Australia, St John Ambulance WA, and Mylan Specialty Limited.
- Short Bio:B Pharm PGrad Dip Pharm (Clinical) PhD